ArticleCancer chemotherapy and pharmacology2025

Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib).

Lin Fang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.